The global diabetes treatment devices market is witnessing significant growth, driven by the rising prevalence of diabetes and advancements in medical technology. As the demand for effective diabetes management solutions increases, the market is poised for substantial expansion in the coming years.

The global diabetes treatment devices market size was valued at USD 10.83 billion in 2018 and is projected to reach USD 22.83 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period. North America dominated the global market, holding a share of 40.44% in 2018.

Top Companies in the Diabetes Treatment Devices Market

Leading players in the diabetes treatment devices industry include:

• F. Hoffmann-La Roche Ltd
• Tandem Diabetes Care, Inc.
• B. Braun Melsungen AG
• Medtronic
• BD
• Novo Nordisk A/S
• Abbott
• Sanofi
• Other players

Get More Information: https://www.fortunebusinessinsights.com/industry-reports/diabetes-treatment-devices-market-100777 

Key Industry Developments

• March 2021: F. Hoffmann-La Roche Ltd announced the launch of a new Accu-Check Instant system, a blood glucose monitoring system that supports Roche’s integrated personalized diabetes management approach.
• April 2021: BIOCORP and Roche Diabetes Care, France launched Mallya, a smart insulin injection pen in France, leveraging Roche’s distribution network in pharmacies.

Market Drivers and Restraints

Market Drivers:

• Rising Prevalence of Diabetes: The increasing global incidence of diabetes, particularly in developing economies, is a significant factor propelling market growth.
• Advancements in Insulin Delivery Devices: The introduction of novel, minimally invasive insulin delivery devices enhances patient compliance and drives market expansion.
• Growing Awareness: Increased awareness about advanced insulin delivery devices among diabetic patients augments demand for these devices.
• Public and Private Sector Collaboration: Collaborative efforts to meet diabetes treatment needs and high investment in research and development fuel market growth.

Market Restraints:

• High Cost of Devices: The high cost associated with advanced diabetes treatment devices may hinder market growth, especially in low-income regions.
• Lack of Awareness in Emerging Markets: Limited awareness about diabetes management devices in emerging economies can restrain market expansion.

Market Segments

By Product:

• Insulin Pens
• Insulin Pumps
• Insulin Jet Injectors
• Insulin Syringes
• Others

By Distribution Channel:

• Institutional Sales
• Retail Sales

The retail sales segment is expected to be the leading segment in this market during the forecast period, owing to increased penetration of private-label brands in retail outlets at discounted prices.

Market Regional Insights

North America: North America generated a revenue of USD 4.38 billion in 2018 and is anticipated to grow at a moderate CAGR during the forecast period, driven by increased investment in research and development of novel insulin delivery devices.

Asia Pacific: The Asia Pacific region is expected to grow at a higher CAGR due to the increasing diabetic population, adoption of technologically advanced insulin delivery devices, and demand for minimally invasive devices.

Request a Free Sample PDF Brochure of Diabetes Treatment Devices Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100777

Future Market Scope

The diabetes treatment devices market is poised for robust growth, with technological advancements and strategic collaborations playing a pivotal role. The integration of continuous glucose monitoring systems with insulin delivery devices, development of smart insulin pens, and focus on minimally invasive solutions are expected to shape the future of diabetes management. Additionally, increasing awareness and government initiatives in emerging economies will further drive market expansion.

Conclusion

The global diabetes treatment devices market is on a trajectory of significant growth, fueled by the rising prevalence of diabetes, technological innovations, and collaborative efforts between public and private sectors. As the demand for effective and patient-friendly diabetes management solutions increases, the market is set to offer improved and accessible devices for diabetic patients worldwide.

Frequently Asked Questions (FAQ’s)

1. What is the market size of Diabetes Treatment Devices Market?
2. What factors are driving Diabetes Treatment Devices Market growth in North America?
3. Who are the major players in the Diabetes Treatment Devices Market?

About Us:

Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.

Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.

At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: [email protected]